EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases

Doaa Elsayed Mahmoud iD, Seyedeh Hanieh Hosseini, Hassaan Anwer Rathore, Alaaldin M Alkilany, Andreas Heise iD, Abdelbary Elhissi

Pharmaceutics · 09.07.2025 · 17 (7) · 893

DOI: 10.3390/pharmaceutics17070893 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 09.07.2025. Verfasst von Doaa Elsayed Mahmoud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar University, Royal College of Surgeons in Ireland (RCSI), Qatar National Library.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review explores recent advancements in inhaled nanoparticle formulations and inhalation devices, with a focus on various types of nanoparticles used for inhalation to treat inflammatory lung diseases and the types of devices used in their delivery. Medical nebulizers have been found to be the most appropriate type of inhalation devices for the pulmonary delivery of nanoparticles, since formulations can be prepared using straightforward techniques, with no need for liquefied propellants as in the case of pressurized metered dose inhalers (pMDIs), or complicated preparation procedures as in the case of dry powder inhalers (DPIs). We demonstrated examples of how formulations should be designed considering the operation mechanism of nebulizers, and how an interplay of factors can affect the aerosol characteristics of nanoparticle formulations. Overall, nanoparticle-based formulations offer promising potential for the treatment of inflammatory lung diseases due to their unique physicochemical properties and ability to provide localized drug delivery in the lung following inhalation.

Schlagwörter

Stichwörter der Autor:innen

drug deliveryinflammatory lung disordersinhalation devicesnanoparticles

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar.
  • Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar.
  • Department of Chemistry, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.

ORCID-Profile: Doaa Elsayed Mahmoud, Andreas Heise

Förderung

  • Qatar University
  • Royal College of Surgeons in Ireland (RCSI)
  • Qatar National Library

Zitieren

APA

Mahmoud, D. E., Hosseini, S. H., Rathore, H. A., Alkilany, A. M., Heise, A., & Elhissi, A. (2025). Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases. Pharmaceutics, 17(7), 893. https://doi.org/10.3390/pharmaceutics17070893

Vancouver

Mahmoud DE, Hosseini SH, Rathore HA, Alkilany AM, Heise A, Elhissi A. Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases. Pharmaceutics. 2025;17(7):893. doi:10.3390/pharmaceutics17070893

BibTeX
@article{Mahmoud2025,
  author = {Mahmoud, Doaa Elsayed and Hosseini, Seyedeh Hanieh and Rathore, Hassaan Anwer and Alkilany, Alaaldin M and Heise, Andreas and Elhissi, Abdelbary},
  title = {Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {893},
  doi = {10.3390/pharmaceutics17070893}
}
Kostenlos starten →